Sodium channel blockers for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sodium Channel Blockers for Cystic Fibrosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454740/all/Sodium_channel_blockers_for_cystic_fibrosis.
Sodium channel blockers for cystic fibrosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454740/all/Sodium_channel_blockers_for_cystic_fibrosis. Accessed November 1, 2024.
Sodium channel blockers for cystic fibrosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454740/all/Sodium_channel_blockers_for_cystic_fibrosis
Sodium Channel Blockers for Cystic Fibrosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 November 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454740/all/Sodium_channel_blockers_for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium channel blockers for cystic fibrosis
ID - 454740
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454740/all/Sodium_channel_blockers_for_cystic_fibrosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -